VacZine Analytics releases MarketVIEW: diabetes vaccines

Today UK-based strategic research consultancy VacZine Analytics releases a new commercial market forecast for diabetes vaccines.

MarketVIEW: diabetes vaccines is a comprehensive MS Excel-based model + summary presentation which forecasts the potential commercial value of diabetes vaccines across major Western  markets until 2030.

The model contains value ($ m) and volume (mio doses) predictions along with timeframe, pricing and penetration estimates for all adult/pediatric risk groups depending on stage of diabetes/risk profile. The product also includes an up-to-date review of disease epidemiology and competitor R&D pipeline activity.

______________________________________________



Read more

Looking for something specific?